Navigation Links
Commentary in The Lancet on the Declaration of Istanbul Sees Organ Transplantation Worldwide Threatened by Organ Trafficking and Transplant Tourism and Commercialism
Date:7/3/2008

BOSTON, Massachusetts, July 3 /PRNewswire/ -- The July 5 issue of the leading medical journal, The Lancet, highlights the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, an important affirmation of ethical principles and practices adopted on May 2, 2008, at an International Summit of more than 150 healthcare professionals, officials, scientists, ethicists and legal scholars from 78 countries and 20 international organizations. A Commentary, authored by the 32-member Steering Committee of the Istanbul Summit, describes how the policies advocated by the Declaration will help to combat the trafficking of people as a source of human organs for transplantation, and the transplant tourism which depends on organ sales and undermines countries' efforts to meet the health needs of their own populations. The commentary and the declaration are available at the following Multimedia News release link, please click: http://www.prnewswire.com/mnr/transplantationsociety/33914/

Organ commercialism, which targets vulnerable populations (such as illiterate and impoverished persons, undocumented immigrants, prisoners, and political or economic refugees) in resource-poor countries, has been condemned by international bodies such as the World Health Organization for decades. Yet in recent years, as a consequence of the increasing ease of internet communication and the willingness of patients in rich countries to travel and purchase organs, organ trafficking and transplant tourism have grown into global problems. For example, as of 2006, foreigners received two-thirds of the 2000 kidney transplants performed annually in Pakistan.

The Declaration of Istanbul proclaims that the poor who sell their organs are being exploited, whether by richer people within their own countries or by transplant tourists from abroad. Moreover, transplant tourists risk physical harm by unregulated and illegal transplantation. Participants in the Istanbul Summit concluded that transplant commercialism and tourism and organ trafficking should be prohibited. And they also urged their fellow transplant professionals, individually and through their organizations, to put an end to these unethical activities and foster safe, accountable practices that meet the needs of transplant recipients while protecting donors.

The Commentary points out that countries from which transplant tourists originate, as well as those to which they travel to obtain transplants, are just beginning to address their respective responsibilities to protect their people from exploitation and to develop national self-sufficiency in organ donation. The authors expect that the Declaration will reinforce the resolve of governments and international organizations to develop laws and guidelines to bring an end to wrongful practices. "The legacy of transplantation is threatened by organ trafficking and transplant tourism. The Declaration of Istanbul aims to combat these activities and to preserve the nobility of organ donation. The success of transplantation as a life-saving treatment does not require-nor justify-victimizing the world's poor as the source of organs for the rich."

The Declaration of Istanbul has been endorsed by The Transplantation Society and the International Society of Nephrology, which sponsored the Summit meeting.


'/>"/>
SOURCE The Transplantation Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Lancet Global Health Network
2. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
3. MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
4. New Lancet Study: Tobacco Control Measures Are Effective and Affordable Strategies to Reduce Chronic Disease Deaths Globally
5. Two studies published in the Lancet
6. Telecommunications Carriers Respond To Congress Declaration of April as National 9-1-1 Education Month
7. Figure Skater Peggy Fleming Teams With HealthSaver: Go Organic for Quality, Natural Food
8. Organ Donation: An Advancing Science Hindered by Supply Shortages
9. Latest Research Shows Strong Consumer Demand for Organic Foods
10. Immune Molecule Key to Preventing Organ Rejection
11. Target Debuts Organic Skin Care Line Uniquely Developed from African and Asian Natural Remedies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: